Sage-ONF Launches Innovative Silicone Synthetic Leather for Future Mobility Interiors
20.7.2022 03:00:00 EEST | Business Wire | Press release
Sage-ONF, a synthetic leather supplier boasting 29 years of experience in design, development, manufacturing and sales, launches serial production of Silicone Synthetic leather. The Sage-ONF plant has begun manufacturing the Silicone Synthetic leather in Shanghai, China.
As consumers continue to demand greater sustainability commitments, this new venture extends Sage-ONF’s heritage of sustainability by delivering Silicone Synthetic leather as an innovative petroleum-free, non-carbon-based product solution for today’s mobility interiors. With a steadfast conviction to continuous innovation and earth-friendly business practices, this new material avoids DMF and plasticizer usage.
“Bringing together our core competencies as Sage-ONF, we bridge the gap between consumer expectations and industry capabilities to provide alternatives that are both environmentally friendly and bolster animal welfare around the globe,” said Robbie Lv, General Manager of Sage-ONF.
Sage and ONF bring 74 years in the automotive interiors business and a deep understanding of cultural trends and design preferences to deliver unparalleled luxury and a soft hand feel that consumers demand for interior mobility needs. Beyond the touch, consumers can have confidence in their interior’s longevity and cleanability—simply wipe stains with a damp cloth to remove them.
However, experience proves that interiors must be tough enough to tackle mile after mile with a super resilient resistance to extreme temperatures. Using UV, hydrolysis, cold crack and flame tests, Sage-ONF ensures long-lasting interiors that enhance the consumer mobility experience. While many claim superiorities in luxury or in sustainability, Sage-ONF exceeds expectations in both realms by using non-solvent and plasticizer-free techniques to create an opulent silicone with ultra-low VOCs.
“By keeping our product, process and mission as our guide, we are pleased to create a silicone synthetic leather that meets the demanding needs of the mobility interior without leather’s known fragility, extra weight, environmental impact and short lifespan,” said Mark Brezenski, Vice President – Asia at Sage, an Asahi Kasei company. “Sage-ONF is proud to deliver interior materials and solutions of tomorrow to OEMs and consumers, today.”
About Sage Automotive Interiors
Sage Automotive Interiors (www.sageautomotiveinteriors.com) is one of the world’s leading providers of automotive interior materials—seating, door panel surfaces and headliners—to automotive Original Equipment Manufacturers (OEMs). Global offices and manufacturing locations include the U.S., South America, EMEA and Asia. Sage’s core strengths are consumer research, sustainability and innovative problem solving for the OEM. Sage’s vision is to continually lead the market in design, engineering and technical capability, supported by world-class manufacturing. Sage Automotive Interiors is an Asahi Kasei company.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220715005491/en/
Contact information
Reader Inquiries & Editorial Contacts:
Michele Wascavage, Sage Automotive Interiors
Global Marketing Director
Michele.wascavage@sageai.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom